We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
-3.84%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$6.16B
AUM Growth
+$1.7B
Cap. Flow
+$2.17B
Cap. Flow %
35.15%
Top 10 Hldgs %
26.62%
Holding
7,028
New
630
Increased
3,221
Reduced
2,151
Closed
574

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$204M
2
MSFT icon
Microsoft
MSFT
+$195M
3
AMZN icon
Amazon
AMZN
+$97.4M
4
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$95M
5
TSM icon
TSMC
TSM
+$69.5M

Sector Composition

Rank Sector Weight
1 Technology 27%
2 Healthcare 10.88%
3 Consumer Discretionary 10.71%
4 Financials 8.69%
5 Communication Services 7.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LEGH icon
3526
Legacy Housing
LEGH
$698M
$33K ﹤0.01%
1,942
-6,170
-76% -$97.9K
MFA
3527
MFA Financial
MFA
$926M
$33K ﹤0.01%
4,282
+198
+5% +$2.21K
MYFW icon
3528
First Western Financial
MYFW
$310M
$33K ﹤0.01%
1,322
-1,461
-52% -$39.9K
POWL icon
3529
Powell Industries
POWL
$7.78B
$33K ﹤0.01%
4,752
+1,545
+48% +$12.4K
SPNT icon
3530
SiriusPoint
SPNT
$2.76B
$33K ﹤0.01%
6,852
-1,673
-20% -$7.78K
TSQ icon
3531
Townsquare Media
TSQ
$104M
$33K ﹤0.01%
4,597
+2,890
+169% +$24.5K
VERA icon
3532
Vera Therapeutics
VERA
$2.28B
$33K ﹤0.01%
1,535
+105
+7% +$1.97K
KVSA
3533
DELISTED
Khosla Ventures Acquisition Co. Class A Common Stock
KVSA
$33K ﹤0.01%
3,420
-5,375
-61% -$52.7K
ADAP
3534
DELISTED
Adaptimmune Therapeutics
ADAP
$32K ﹤0.01%
29,870
+486
+2% +$893
AMSF icon
3535
AMERISAFE
AMSF
$513M
$32K ﹤0.01%
686
-5,573
-89% -$269K
APYX icon
3536
Apyx Medical
APYX
$128M
$32K ﹤0.01%
7,147
+6,952
+3,565% +$49.8K
BHP icon
3537
BHP
BHP
$220B
$32K ﹤0.01%
632
-4,119
-87% -$218K
CCO icon
3538
Clear Channel Outdoor Holdings
CCO
$1.19B
$32K ﹤0.01%
23,121
+3,341
+17% +$5.05K
CDLX icon
3539
Cardlytics
CDLX
$24.9M
$32K ﹤0.01%
341
+235
+222% +$33.4K
CSAN icon
3540
Cosan
CSAN
$2.48B
$32K ﹤0.01%
+2,425
New +$34.8K
ENVB icon
3541
Enveric Biosciences
ENVB
$6.16M
$32K ﹤0.01%
43
+38
+760% +$47.8K
EQH icon
3542
Equitable Holdings
EQH
$14.5B
$32K ﹤0.01%
1,210
-4,184
-78% -$119K
FWRG icon
3543
First Watch Restaurant Group
FWRG
$785M
$32K ﹤0.01%
2,274
+1,775
+356% +$28.8K
GNK icon
3544
Genco Shipping & Trading
GNK
$1.15B
$32K ﹤0.01%
2,603
+1,387
+114% +$22K
HESM icon
3545
Hess Midstream
HESM
$5.2B
$32K ﹤0.01%
+1,248
New +$35.7K
IBRX icon
3546
ImmunityBio
IBRX
$8.02B
$32K ﹤0.01%
6,448
+670
+12% +$3.05K
JMIA
3547
Jumia Technologies
JMIA
$772M
$32K ﹤0.01%
5,467
+4,893
+852% +$33.4K
LIND icon
3548
Lindblad Expeditions
LIND
$2.2B
$32K ﹤0.01%
4,729
-329
-7% -$2.87K
LIVE icon
3549
Live Ventures
LIVE
$31.9M
$32K ﹤0.01%
1,297
+626
+93% +$17.9K
MDV
3550
Modiv Industrial
MDV
$32K ﹤0.01%
2,367
+2,236
+1,707% +$32.1K

Similar funds

Tower Research Capital (TRC)'s Q3 2022 Portfolio in Review

As of Q3 2022, Tower Research Capital (TRC) held 7,028 positions worth $6.16B, up 38% from $4.46B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Tower Research Capital (TRC) deployed $2.17B of net new capital in Q3 2022, opening 630 new positions and adding to 3,221 existing holdings. Its largest new stake was iShares Core S&P Mid-Cap ETF: 347,965 shares worth $15.3M.

By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 23% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was iShares Russell 2000 ETF, an estimated $53M trimmed.

  • Tower Research Capital (TRC)'s largest Q3 2022 buy was iShares Core S&P Mid-Cap ETF: 347,965 shares worth $15.3M.
  • Tower Research Capital (TRC) added most to Apple in Q3 2022, an estimated $204M increase.
  • Tower Research Capital (TRC)'s biggest Q3 2022 reduction was iShares Russell 2000 ETF, cutting an estimated $53M.
  • Tower Research Capital (TRC) fully exited State Street SPDR Portfolio S&P 500 ETF in Q3 2022, selling an estimated $6.39M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 27% of its $6.16B portfolio in Q3 2022.
  • Tower Research Capital (TRC) opened 630 new positions and closed 574 in Q3 2022.
  • Tower Research Capital (TRC)'s portfolio value rose 38% quarter-over-quarter to $6.16B.

Based on Tower Research Capital (TRC)'s 13F filing for Q3 2022, filed 10 Nov 2022.